Literature DB >> 24677570

Classical endocannabinoid-like compounds and their regulation by nutrients.

Karen Kleberg1, Helle A Hassing, Harald S Hansen.   

Abstract

Endocannabinoid-like compounds are structurally related to the true endocannabinoids but do not contain highly unsaturated fatty acids, and they do not bind the cannabinoid receptors. The classical endocannabinoid-like compounds include N-acylethanolamines and 2-monoacylglycerols, and their structural resemblance to the endocannabinoids makes them players in the endocannabinoid system, where they can interfere with the actions of the true endocannabinoids, because they in several cases engage the same synthesizing and degrading enzymes. In addition they have pharmacological actions of their own, which are particularly interesting in a nutritional and metabolic context. Exogenously supplied oleoylethanolamide, palmitoylethanolamide, and linoleoylethanolamide have anorexic effects, and the endogenous formation of these N-acylethanolamines in the small intestine may serve an important role in regulating food intake, through signaling via PPARα and the vagus nerve to the brain appetite center. A chronic high-fat diet will decrease intestinal levels of these anorectic N-acylethanolamines and this may contribute to the hyperphagic effect of high-fat diet; 2-monoacylglycerols mediate endocrine responses in the small intestine; probably trough activation of GPR119 on enteroendocrine cells, and diet-derived 2-monoacylglycerols, for example, 2-oleoylglycerol and 2-palmitoylglycerol might be important for intestinal fat sensing. Whether these 2-monoacylglycerols have signaling functions in other tissues is unclear at present.
© 2014 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  2-oleoylglycerol; N-acylethanolamine; dietary fat; monoacylglycerol; oleoylethanolamide

Mesh:

Substances:

Year:  2014        PMID: 24677570     DOI: 10.1002/biof.1158

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  17 in total

1.  Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol.

Authors:  E C Hanlon; E Tasali; R Leproult; K L Stuhr; E Doncheck; H de Wit; C J Hillard; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

2.  Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling.

Authors:  Yu-Hong Cheng; Mei-Shang Ho; Wei-Ting Huang; Ying-Ting Chou; Klim King
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

3.  Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol.

Authors:  Karen Kleberg; Anne Katrine Jacobsen; Jozelia G Ferreira; Johanne Agerlin Windeløv; Jens F Rehfeld; Jens Juul Holst; Ivan E de Araujo; Harald S Hansen
Journal:  J Physiol       Date:  2015-02-09       Impact factor: 5.182

Review 4.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

Review 5.  The Endocannabinoid System and Eating Behaviours: a Review of the Current State of the Evidence.

Authors:  Nathaly Aguilera Vasquez; Daiva E Nielsen
Journal:  Curr Nutr Rep       Date:  2022-08-18

Review 6.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

7.  Structural equation modeling of food craving across the menstrual cycle using behavioral, neuroendocrine, and metabolic factors.

Authors:  Sridevi Krishnan; Karan Agrawal; Rebecca R Tryon; Lucas C Welch; William F Horn; John W Newman; Nancy L Keim
Journal:  Physiol Behav       Date:  2018-07-18

8.  Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol.

Authors:  Erin C Hanlon; Esra Tasali; Rachel Leproult; Kara L Stuhr; Elizabeth Doncheck; Harriet de Wit; Cecilia J Hillard; Eve Van Cauter
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

Review 9.  Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies.

Authors:  Cynthia J M Kane; Paul D Drew
Journal:  J Leukoc Biol       Date:  2016-07-26       Impact factor: 4.962

Review 10.  Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine.

Authors:  Harald S Hansen; Vasiliki Vana
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.